Home » Topics » Science » New compound

New compound
RSS

GSK-701: a first-in-class clinical antimalarial candidate with good oral bioavailability

Aug. 30, 2018

Potential new anti-obesity target identified

Aug. 29, 2018

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Aug. 27, 2018

GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain

Aug. 22, 2018

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Aug. 22, 2018

New oral selective apelin agonist AM-2995 developed for heart disease treatment

Aug. 21, 2018

HDAC inhibitors optimized for CNS drug-like properties and hematological safety

Aug. 21, 2018

Development of riluzole prodrugs for the treatment of amyotrophic lateral sclerosis

Aug. 14, 2018

Discovery of a potent and selective receptor antagonist for the treatment of asthma

Aug. 13, 2018

Researchers discover potent and selective histone deacetylase 11 inhibitors

Aug. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...